Cargando…
Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3
Molecular interactions between anorexigenic leptin and orexigenic endocannabinoids, although of great metabolic significance, are not well understood. We report here that hypothalamic STAT3 signaling in mice, initiated by physiological elevations of leptin, is diminished by agonists of the cannabino...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392084/ https://www.ncbi.nlm.nih.gov/pubmed/37534180 http://dx.doi.org/10.1016/j.isci.2023.107207 |
_version_ | 1785082870956556288 |
---|---|
author | Szanda, Gergő Jourdan, Tony Wisniewski, Éva Cinar, Resat Godlewski, Grzegorz Rajki, Anikó Liu, Jie Chedester, Lee Szalai, Bence Tóth, András Dávid Soltész-Katona, Eszter Hunyady, László Inoue, Asuka Horváth, Viktória Bea Spät, András Tam, Joseph Kunos, George |
author_facet | Szanda, Gergő Jourdan, Tony Wisniewski, Éva Cinar, Resat Godlewski, Grzegorz Rajki, Anikó Liu, Jie Chedester, Lee Szalai, Bence Tóth, András Dávid Soltész-Katona, Eszter Hunyady, László Inoue, Asuka Horváth, Viktória Bea Spät, András Tam, Joseph Kunos, George |
author_sort | Szanda, Gergő |
collection | PubMed |
description | Molecular interactions between anorexigenic leptin and orexigenic endocannabinoids, although of great metabolic significance, are not well understood. We report here that hypothalamic STAT3 signaling in mice, initiated by physiological elevations of leptin, is diminished by agonists of the cannabinoid receptor 1 (CB(1)R). Measurement of STAT3 activation by semi-automated confocal microscopy in cultured neurons revealed that this CB(1)R-mediated inhibition requires both T cell protein tyrosine phosphatase (TC-PTP) and β-arrestin1 but is independent of changes in cAMP. Moreover, β-arrestin1 translocates to the nucleus upon CB(1)R activation and binds both STAT3 and TC-PTP. Consistently, CB(1)R activation failed to suppress leptin signaling in β-arrestin1 knockout mice in vivo, and in neural cells deficient in CB(1)R, β-arrestin1 or TC-PTP. Altogether, CB(1)R activation engages β-arrestin1 to coordinate the TC-PTP-mediated inhibition of the leptin-evoked neuronal STAT3 response. This mechanism may restrict the anorexigenic effects of leptin when hypothalamic endocannabinoid levels rise, as during fasting or in diet-induced obesity. |
format | Online Article Text |
id | pubmed-10392084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103920842023-08-02 Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 Szanda, Gergő Jourdan, Tony Wisniewski, Éva Cinar, Resat Godlewski, Grzegorz Rajki, Anikó Liu, Jie Chedester, Lee Szalai, Bence Tóth, András Dávid Soltész-Katona, Eszter Hunyady, László Inoue, Asuka Horváth, Viktória Bea Spät, András Tam, Joseph Kunos, George iScience Article Molecular interactions between anorexigenic leptin and orexigenic endocannabinoids, although of great metabolic significance, are not well understood. We report here that hypothalamic STAT3 signaling in mice, initiated by physiological elevations of leptin, is diminished by agonists of the cannabinoid receptor 1 (CB(1)R). Measurement of STAT3 activation by semi-automated confocal microscopy in cultured neurons revealed that this CB(1)R-mediated inhibition requires both T cell protein tyrosine phosphatase (TC-PTP) and β-arrestin1 but is independent of changes in cAMP. Moreover, β-arrestin1 translocates to the nucleus upon CB(1)R activation and binds both STAT3 and TC-PTP. Consistently, CB(1)R activation failed to suppress leptin signaling in β-arrestin1 knockout mice in vivo, and in neural cells deficient in CB(1)R, β-arrestin1 or TC-PTP. Altogether, CB(1)R activation engages β-arrestin1 to coordinate the TC-PTP-mediated inhibition of the leptin-evoked neuronal STAT3 response. This mechanism may restrict the anorexigenic effects of leptin when hypothalamic endocannabinoid levels rise, as during fasting or in diet-induced obesity. Elsevier 2023-06-25 /pmc/articles/PMC10392084/ /pubmed/37534180 http://dx.doi.org/10.1016/j.isci.2023.107207 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Szanda, Gergő Jourdan, Tony Wisniewski, Éva Cinar, Resat Godlewski, Grzegorz Rajki, Anikó Liu, Jie Chedester, Lee Szalai, Bence Tóth, András Dávid Soltész-Katona, Eszter Hunyady, László Inoue, Asuka Horváth, Viktória Bea Spät, András Tam, Joseph Kunos, George Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title | Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title_full | Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title_fullStr | Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title_full_unstemmed | Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title_short | Cannabinoid receptor type 1 (CB(1)R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 |
title_sort | cannabinoid receptor type 1 (cb(1)r) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with tc-ptp and stat3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392084/ https://www.ncbi.nlm.nih.gov/pubmed/37534180 http://dx.doi.org/10.1016/j.isci.2023.107207 |
work_keys_str_mv | AT szandagergo cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT jourdantony cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT wisniewskieva cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT cinarresat cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT godlewskigrzegorz cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT rajkianiko cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT liujie cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT chedesterlee cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT szalaibence cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT tothandrasdavid cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT solteszkatonaeszter cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT hunyadylaszlo cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT inoueasuka cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT horvathviktoriabea cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT spatandras cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT tamjoseph cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 AT kunosgeorge cannabinoidreceptortype1cb1rinhibitshypothalamicleptinsignalingviabarrestin1incomplexwithtcptpandstat3 |